[1] Alter MJ,Mast EE.The epidemiology of viral hepatitis in the United States. Gastroenterol Clin North Am,1994,23:437-455.
[2] Thimme R,Wieland S,Steiger C,et al.CD8(+)T cells mediate viral clearance and disease pathogenesis during acute hepatitis B virus infection. J Virol,2003,77:68-76.
[3] Rehermann B,Nascimbeni M.Immunology of hepatitis B virus and hepatitis C virus infection. Nat Rev Immunol,2005,5:215-229.
[4] Alroqi FJ,Chatila TA.T regulatory cell biology in health and disease. Curr Allergy Asthma Rep,2016,16:27.
[5] Gershon RK.A disquisition on suppressor T cells. Transplant Rev,1975,26:170-185.
[6] Sakaguchi S,Fukuma K,Kuribayashi K,et al.Organ-specific autoimmune diseases induced in mice by elimination of T cell subset. I. Evidence for the active participation of T cells in natural self-tolerance;deficit of a T cell subset as a possible cause of autoimmune disease. J Exp Med,1985,161:72-87.
[7] Sakaguchi S,Sakaguchi N,Asano M,et al.Immunologic self-tolerance maintained by activated T cells expressing IL-2 receptor alpha-chains(CD25). Breakdown of a single mechanism of self-tolerance causes various autoimmune diseases. J Immunol,1995,155:1151-1164.
[8] Baecher-Allan C,Viglietta V,Hafler DA.Human CD4+CD25+ regulatory T cells. Semin Immunol,2004,16:89-98.
[9] Hori S,Nomura T,Sakaguchi S.Control of regulatory T cell development by the transcription factor Foxp3. Science,2003,299:1057-1061.
[10] Bettelli E,Carrier Y,Gao W,et al.Reciprocal developmentalpathways for the generation of pathogenic effector TH17 and regulatory T cells. Nature,2006,441:235-238.
[11] Mills KH. Regulatory T cells:friend or foe in immunity to infection Nat Rev Immunol,2004,4:841-855.
[12] Sakaguchi S.Naturally arising Foxp3-expressing CD25+CD4+ regulatory T cells in immunological tolerance to self and non-self. Nat Immunol,2005,6:345-352.
[13] Jordan MS,Boesteanu A,Reed AJ,et al.Thymic selection of CD4+CD25+ regulatory T cells induced by an agonist self-peptide. Nat Immunol,2001,2:301-306.
[14] Andre S,Tough DF,Lacroix-Desmazes S,et al.Surveillance of antigen-presenting cells by CD4+CD25+ regulatory T cells in autoimmunity:immunopathogenesis and therapeutic implications. Am J Pathol,2009,174:1575-1587.
[15] Walker MR,Kasprowicz DJ,Gersuk VH,et al.Induction of FoxP3 and acquisition of T regulatory activity by stimulated human CD4+CD25-T cells. J Clin Invest,2003,112:1437-1443.
[16] Groux H,Fournier N,Cottrez F.Role of dendritic cells in the generation of regulatory T cells. Semin Immunol,2004,16:99-106.
[17] Lu Y,Wang X,Gu J,et al.iTreg induced from CD39(+) naive T cells demonstrate enhanced proliferate and suppressive ability. Int Immunopharmacol,2015,28:925-930.
[18] Trehanpati N,Shrivastav S,Shivakumar B,et al.Analysis of notch and TGF-beta signaling expression in different stages of disease progression during hepatitis B virus infection. Clin Transl Gastroenterol,2012,3:e23.
[19] Asano N,Watanabe T,Kitani A,et al.Notch1 signaling and regulatory T cell function. J Immunol,2008,180:2796-2804.
[20] Moore KW,de Waal Malefyt R,Coffman RL,et al. Interleukin-10 and the interleukin-10 receptor. Annu Rev Immunol,2001,19:683-765.
[21] Read S,Malmstrom V,Powrie F.Cytotoxic T lymphocyte-associated antigen 4 plays an essential role in the function of CD25(+)CD4(+) regulatory cells that control intestinal inflammation. J Exp Med,2000,192:295-302.
[22] de la Rosa M,Rutz S,Dorninger H,et al. Interleukin-2 is essential for CD4+CD25+ regulatory T cell function. Eur J Immunol,2004,34:2480-2488.
[23] Tran DQ,Glass DD,Uzel G,et al.Analysis of adhesion molecu-les,target cells,and role of IL-2 in human FOXP3+ regulatory T cell suppressor function. IL-2 in human FOXP3+ regulatory T cell suppressor function. J Immunol,2009,182:2929-2938.
[24] Collison LW,Workman CJ,Kuo TT,et al.The inhibitory cytokine IL-35 contributes to regulatory T-cell function. Nature,2007,450:566-569.
[25] Collison LW,Chaturvedi V,Henderson AL,et al.IL-35-mediated induction of a potent regulatory T cell population. Nat Immunol,2010,11:1093-1101.
[26] Chaturvedi V,Collison LW,Guy CS,et al.Cutting edge:Human regulatory T cells require IL-35 to mediate suppression and infectious tolerance. J Immunol,2011,186:6661-6666.
[27] Dietze KK,Schimmer S,Kretzmer F,et al.Characterization of the Treg response in the hepatitis B virus hydrodynamic injection mouse model. PloS one,2016,11:e0151717.
[28] Stross L,Gunther J,Gasteiger G,et al.Foxp3+ regulatory T cells protect the liver from immune damage and compromise virus control during acute experimental hepatitis B virus infection in mice. Hepatology,2012,56:873-883.
[29] Xu D,Fu J,Jin L,et al.Circulating and liver resident CD4+CD25+ regulatory T cells actively influence the antiviral immune response and disease progression in patients with hepatitis B. J Immunol,2006,177:739-747.
[30] Yan Z,Zhou J,Zhang M,et al.Telbivudine decreases proportion of peripheral blood CD4+CD25+CD127low T cells in parallel with inhibiting hepatitis B virus DNA. Mol Med Rep,2014,9:2024-2030.
[31] Stoop JN,van der Molen RG,Kuipers EJ,et al. Inhibition of viral replication reduces regulatory T cells and enhances the antiviral immune response in chronic hepatitis B. Virology,2007,361:141-148.
[32] Feng H,Yin J,Han YP,et al.Sustained changes of Treg and Th17 cells during interferon-alpha therapy in patients with chronic hepatitis B. Viral Immunol,2015,28:412-417.
[33] Yang X,Li J,Liu J,et al.Relationship of Treg/Th17 balance with HBeAg change in HBeAg-positive chronic hepatitis B patients receiving telbivudine antiviral treatment:A longitudinal observational study. Medicine (Baltimore),2017,96:e7064.
[34] Das A,Ellis G,Pallant C,et al.IL-10-producing regulatory B cells in the pathogenesis of chronic hepatitis B virus infection. J Immunol,2012,189:3925-3935.
[35] Xiang XG,Xie Q.IL-35:a potential therapeutic target for controlling hepatitis B virus infection. J Dig Dis,2015,16:1-6.
[36] Wang X,Dong Q,Li Q,et al.Dysregulated response of follicular helper T cells to hepatitis B surface antigen promotes HBV persistence in mice and associates with outcomes of patients. Gastroenterology,2018,154:2222-2236. |
